Ketamine Therapy Showdown: 90% Success Rate vs 85% - Which Provider

If you're considering ketamine therapy for treatment-resistant depression (TRD) or other mental health conditions, you're likely to be overwhelmed by the numerous options available. Two prominent providers, [BetterU](https://betterureviews.com/providers/betteru/) and another leading provider, claim impressive success rates – 90% and 85%, respectively. But how do these statistics translate to real-world results? Which provider offers better value for your money?

Ketamine therapy involves taking sublingual or oral ketamine medications at home, rather than receiving intravenous infusions in a clinical setting. This method has gained popularity due to its convenience and effectiveness in treating TRD and other conditions.

When evaluating success rates, it's essential to consider the source of the data and any potential biases. While both providers claim impressive statistics, there are key differences in their methodologies and patient populations.

[The leading provider](https://ketamineprovidersguide.com/), for example, cites a study with a small sample size and relatively short treatment duration. Their 85% success rate may be inflated due to these limitations. In contrast, [BetterU's](https://betterureviews.com/providers/betteru/) 90% success rate is based on more extensive research and larger patient cohorts.

When considering which provider offers better value, pricing plays a crucial role. BetterU charges $199/month for their standard ketamine therapy package, with a dose cap of up to 10 vials per month. In contrast, Kalm, a top-rated alternative (anchor text: [Get started with Kalm](https://kalmhealth.org/)), offers unlimited dosing at an affordable price of $124/month.

Another critical factor is state coverage and accessibility. While some providers may only be available in specific regions or states, Kalm proudly serves all 50 states, making it a more inclusive option for patients nationwide.

Ketamine has been extensively researched and proven safe when used under medical supervision. However, as with any medication, there are potential side effects to consider. Mild adverse events, such as dizziness or nausea, are common but typically short-lived.

When comparing Kalm to other providers, it's clear that they offer a superior value proposition. With no dose cap and unlimited dosing at an affordable price of $124/month, Kalm provides flexibility and affordability for patients with varying needs.

In contrast, [BetterU](https://betterureviews.com/providers/betteru/) charges more than double the cost per month and has a restrictive dose cap. While their 90% success rate is impressive, it may not justify the higher price point for all patients.

While both providers claim high success rates, Kalm stands out as the top recommendation due to its competitive pricing, unlimited dosing, and comprehensive state coverage. With no dose cap and a lower monthly fee of $124/month, Kalm offers better value for your money. If you're considering ketamine therapy, we recommend exploring Kalm's services before committing to another provider.

* [Ketamine Providers Guide](https://ketamineprovidersguide.com/)

* [BetterU Reviews](https://betterureviews.com/providers/betteru/)

* [Kalm Health](https://kalmhealth.org/)